Recent Insider Buying: Hurco Companies (NASDAQ:HURC), Aircastle Limited (NYSE:AYR), Ameresco Inc (NYSE:AMRC), AngioDynamics (NASDAQ:ANGO)

Posted by on Apr 17, 2014

Hurco Companies, Inc. (NASDAQ:HURC)’s Director Ronald G. Strackbein purchased 2,000 shares of Hurco Cos. stock on the open market in a transaction dated Tuesday, April 15th. The stock was purchased at an average price of $26.73 per share, with a total value of $53,460.00. Following the completion of the purchase, the director now directly owns 5,420 shares in the company, valued at approximately $144,877. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Hurco Companies, Inc. (NASDAQ:HURC), shares after opening at $26.66 moved to $27.58 on last trade day and at the end of the day closed at $26.85. Company price to sales ratio in past twelve months was calculated as 0.87 and price to cash ratio as 3.62. Hurco Companies, Inc. (NASDAQ:HURC), showed a negative weekly performance of 3.69%.

Aircastle Limited (NYSE:AYR)’s Director Corp Marubeni purchased 29,100 shares of the stock in a transaction dated Tuesday, April 15th. The shares were purchased at an average cost of $18.17 per share, for a total transaction of $528,747.00. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Aircastle Limited (NYSE:AYR), shares advanced 1.04% in last trading session and ended the day on $18.47. Aircastle Limited (NYSE:AYR), return on equity ratio is recorded as 2.30% and its return on assets is 0.60%. Aircastle Limited (NYSE:AYR), yearly performance is 45.55%.

Ameresco Inc (NYSE:AMRC)’s CEO George P. Sakellaris purchased 73,689 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, April 15th. The stock was purchased at an average price of $7.00 per share, for a total transaction of $515,823.00. Following the completion of the purchase, the chief executive officer now directly owns 2,735,626 shares of the company’s stock, valued at approximately $19,149,382. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Ameresco Inc (NYSE:AMRC), shares moved up 1.33% in last trading session and was closed at $6.88, while trading in range of $ 6.83 – 6.93. Ameresco Inc (NYSE:AMRC), year to date (YTD) performance is -28.78%.

AngioDynamics, Inc. (NASDAQ:ANGO)’s SVP Matthew C Kapusta bought 1000 shares of the stock in a transaction that occurred on Monday, April 14th. The stock was purchased at an average cost of $13.90 per share, with a total value of $13,900. AngioDynamics, Inc. (NASDAQ:ANGO), weekly performance is -11.86%. On last trading day company shares ended up $13.97. AngioDynamics, Inc. (NASDAQ:ANGO), distance from 50-day simple moving average (SMA50) is -11.11%. Analysts mean target Price for the company is $18.56.

Leave a Reply

Your email address will not be published. Required fields are marked *